Evidence map›Paper›PMID 34491455›Full record

ArticleAMB Express2021

Asphaltene biotransformation for heavy oil upgradation.

Arif Nissar Zargar, Ankur Kumar, Anurag Sinha, Manoj Kumar, Ioannis Skiadas, Saroj Mishra, Preeti Srivastava

Abstract read
In one paragraph

Article in AMB Express, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Asphaltene biotransformation by a novel enzyme thiol peroxidase fromApplied and environmental microbiology · 2025
    Article
  4. Article
  5. Article
  6. Complete Genome Analysis ofMicroorganisms · 2022
    Article
  7. Draft Genome Sequence ofMicrobiology resource announcements · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Arif Nissar ZargarDepartment of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, 110016, India.
Ankur KumarDepartment of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, 110016, India.
Anurag SinhaDepartment of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, 110016, India.
Manoj KumarIndian Oil Corporation, R&D Centre, Sector 13, Faridabad, Haryana, India.
Ioannis SkiadasDepartment of Chemical Engineering, Technical University of Denmark, Lyngby, Denmark.
Saroj MishraDepartment of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, 110016, India.
Preeti SrivastavaDepartment of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, 110016, India. preeti@dbeb.iitd.ac.in.ORCID http://orcid.org/0000-0003-2645-5495

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, the reserves of heavy crude oil are seven times more abundant than that of light crude, and yet, they are underutilized because of their high viscosity and density, which is largely due to the presence of large amounts of asphaltenes. Biotransformation of heavy oil asphaltenes into smaller metabolites can be used for reducing their viscosity. Several microorganisms capable of asphaltene biodegradation have been reported but only few have been characterized for its biotransformation. In the present study, a 9-membered microbial consortium was isolated from an oil contaminated soil. About 72% and 75% asphaltene biotransformation was achieved by growing cells at shake flask level and in a 1.5 l bioreactor, respectively. A representative structure of asphaltene was constructed based on LC-MS,

Indexed as

AsphalteneBacterial consortiumHeavy coilReactorViscosity

Identifiers

PMID34491455
PMCPMC8423941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.